Canaccord analyst Robert Young raised the firm’s price target on Celestica to $38 from $32.50 and keeps a Buy rating on the shares. The firm noted they reported strong Q4 results with all metrics ahead of consensus and provided a Q1 outlook ahead of expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLS: